ROCIO GOMEZ

Dr. ROCIO GOMEZ

Toxicology, CINVESTAV, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JGJorge E. Gutiérrez-Virgen
Jorge E. Gutiérrez-Virgen
MPMaricela Piña-Pozas
Maricela Piña-Pozas
EHEsther A. Hernández-Tobías
Esther A. Hernández-Tobías
LTLUCIA TAJA-CHAYEB
LUCIA TAJA-CHAYEB
MLMa. de Lourdes López-González
Ma. de Lourdes López-González
RGROCIO GOMEZ
ROCIO GOMEZ
ArylamineN-acetyltransferase 2 has been related to drug side effects and cancer susceptibility; its protein structure and acetylation capacity results from the polymorphism’s arrays on theNAT2 gene. Absorption, distribution, metabolism, and excretion, cornerstones of the pharmacological effects, have shown diversity patterns across populations, ethnic groups, and even interethnic variation. Although the 1000 Genomes Project database has portrayed the global diversity of theNAT2 polymorphisms, several populations and ethnicities remain underrepresented, limiting the comprehensive picture of its variation. TheNAT2 clinical entails require a detailed landscape of its striking diversity. This systematic review spans the genetic and acetylation patterns from 164 articles from October 1992 to October 2020. Descriptive studies and controls from observational studies expanded theNAT2 diversity landscape. Our study included 243 different populations and 101 ethnic minorities, and, for the first time, we presented the global patterns in the Middle Eastern populations. Europeans, including its derived populations, and East Asians have been the most studied genetic backgrounds. Contrary to the popular perception, Africans, Latinos and Native Americans have been significantly represented in recent years.NAT2*4, *5B, and *6A were the most frequent haplotypes globally. Nonetheless, the distribution of *5B and *7B were less and more frequent in Asians, respectively. Regarding the acetylator status, East Asians and Native Americans harboured the highest frequencies of the fast phenotype, followed by South Europeans. Central Asia, the Middle East, and West European populations were the major carriers of the slow acetylator status. The detailed panorama presented herein, expands the knowledge about the diversity patterns to genetic and acetylation levels. These data could help clarify the controversial findings between acetylator states and the susceptibility to diseases and reinforce the utility ofNAT2 in precision medicine.

15 September 2012 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
GNGino Noris
Gino Noris
CSCarla Santana
Carla Santana
MMMarco Antonio Meraz-Ríos
Marco Antonio Meraz-Ríos
MMMaria De Lourdes Muñoz
Maria De Lourdes Muñoz
AMAbraham Majluf-Cruz
Abraham Majluf-Cruz
RGROCIO GOMEZ
ROCIO GOMEZ

29 November 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
JPJosé Ricardo Palacios
José Ricardo Palacios
YJYesenia Itzel Martinez Jimenez
Yesenia Itzel Martinez Jimenez
VTVanessa Morillon Torres
Vanessa Morillon Torres
OMOmar Benjamin Rivera Maya
Omar Benjamin Rivera Maya
RGROCIO GOMEZ
ROCIO GOMEZ
ECEmma S Calderon-Aranda
Emma S Calderon-Aranda
The “One Health approach” has evidenced the significant impact of xenobiotic exposure to health, and humans are a relevant target for their toxic effects. Bisphenol A (BPA) exerts a ubiquitous exposure source in all ecosystems. Given its endocrine-disrupting and harmful consequences on health, several countries have enforced new regulations to reduce exposure to BPA. Cardiovascular diseases (CVDs) are complex conditions that lead to higher mortality worldwide, where family history, lifestyle, and environmental factors, like BPA exposure, have a remarkable contribution. This chemical compound is the most widely used in plastic and epoxy resin manufacturing and has been associated with effects on human health. Therefore, new-generation bisphenols (NGBs) are replacing BPA use, arguing that they do not harm health. Nonetheless, the knowledge about whether NGBs are secure options is scanty. Although BPA’s effects on several organs and systems have been documented, the role of BPA and NGBs in CVDs has yet to be explored. This review’s goals are focused on the processes of endothelial activation (EA)–endothelial dysfunction (ED), a cornerstone of CVDs development, bisphenols’ (BPs) effects on these processes through oxidant and antioxidant system alteration. Despite the scarce evidence on pro-oxidant effects associated with NGBs, our review demonstrated a comparable harmful effect on BPA. The results from the present review suggest that the biological mechanisms to explain BPs cardiotoxic effects are the oxidant stress ↔ inflammatory response ↔ EA ↔ ED → atherosclerotic plate → coagulation promotion. Other effects contributing to CVD development include altered lipid metabolism, ionic channels, and the activation of different intracellular pathways, which contribute to ED perpetuation in a concerted manner.

4 July 2023 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
PTPablo Torres-Alamilla
Pablo Torres-Alamilla
RCRocio Castillo-Sanchez
Rocio Castillo-Sanchez
PCPedro Cortes-Reynosa
Pedro Cortes-Reynosa
RGROCIO GOMEZ
ROCIO GOMEZ
ESEduardo Perez Salazar
Eduardo Perez Salazar

16 August 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EÁEsmeralda Álvarez-Topete
Esmeralda Álvarez-Topete
LTLuisa E Torres-Sánchez
Luisa E Torres-Sánchez
EHEsther A Hernández-Tobías
Esther A Hernández-Tobías
DVDavid Veliz
David Veliz
JHJesús Gibran Hernández-Pérez
Jesús Gibran Hernández-Pérez
RGROCIO GOMEZ
ROCIO GOMEZ
Prostate cancer is the second most common neoplasia amongst men worldwide. Hereditary susceptibility and ancestral heritage are well-established risk factors that explain the disparity trends across different ethnicities, populations, and regions even within the same country. The Y-chromosome has been considered a prototype biomarker for male health. African, European, Middle Eastern, and Hispanic ancestries exhibit the highest incidences of such neoplasia; Asians have the lowest rates. Nonetheless, the contribution of ancestry patterns has been scarcely explored among Latino males. The Mexican population has an extremely diverse genetic architecture where all the aforementioned ancestral backgrounds converge. Trans-ethnic research could illuminate the aetiology of prostate cancer, involving the migratory patterns, founder effects, and the ethnic contributions to its disparate incidence rates. The contribution of the ancestral heritage to prostate cancer risk were explored through a case-control study (152 cases and 372 controls) study in Mexican Mestizo males. Seventeen microsatellites were used to trace back the ancestral heritage using two Bayesian predictor methods. The lineage R1a seems to contribute to prostate cancer (ORadjusted:8.04, 95%CI:1.41–45.80) development, whereas E1b1a/E1b1b and GHIJ contributed to well-differentiated (Gleason ≤ 7), and late-onset prostate cancer. Meta-analyses reinforced our findings. The mentioned lineages exhibited a connection with the Middle Eastern and North African populations that enriched the patrilineal diversity to the southeast region of the Iberian Peninsula. This ancestral legacy arrived at the New World with the Spanish and Sephardim migrations. Our findings reinforced the contribution of family history and ethnic background to prostate cancer risk, although should be confirmed using a large sample size. Nonetheless, given its complex aetiology, in addition to the genetic component, the lifestyle and xenobiotic exposition could also influence the obtained results.

1 January 2015 in Genetics and Molecular Research
Verified
Journal Article
Open access
RCR. Camacho-Mejorado
R. Camacho-Mejorado
GNG. Noris
G. Noris
CSC. Santana
C. Santana
JMJonathan J. Magaña
Jonathan J. Magaña
AMA. Majluf-Cruz
A. Majluf-Cruz
RGROCIO GOMEZ
ROCIO GOMEZ
We studied the interethnic variation of the MMP-9 microsatellite in the Mestizo and Amerindian populations using blood samples collected from 435 healthy unrelated individuals from the Central Valley of Mexico. DNA samples were genotyped using the -90 (CA)12-27 repeat near the MMP transcriptional start site using capillary electrophoresis. Our data were compared with those from African, Asian, and European populations (N = 729). Both Mestizo and Amerindian populations were in Hardy-Weinberg equilibrium (P ≥ 0.05). However, strong genetic heterogeneity was found within the Mestizo population (94%, P ≤ 0.0001), which exhibited the highest frequency of Amerindian, African, and European alleles. Likewise, Amerindians showed 6.7% variation among populations (P ≤ 0.0001), suggesting a genetic substructure potentially associated with linguistic affiliations. These findings were corroborated with principal component and population differentiation analyses, which showed relative proximity among the Mestizos and their historical parental populations: Asian (FST ≥ 0.05), European (FST ≥ 0.09), and African (FST ≥ 0.02). Nevertheless, important differences were found between Mestizo and Nahuas (P ≤ 0.0001), and between Mestizo and Me'Phaas (P ≤ 0.0001). These findings highlight the importance of determining local-specific patterns to establish the population variability of MMP-9 and other polymorphic markers. Validation of candidate markers is critical to identifying risk factors; however, this depends on knowledge of population genetic variation, which increases the possibility of finding true causative variants. We also show that dissimilar ethnic backgrounds might lead to spurious associations. Our study provides useful considerations for greater accuracy and robustness in future genetic association studies.